AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,851,075 | -20.3% | 155,599 | -8.8% | 0.01% | -20.0% |
| Q2 2023 | $4,832,270 | +48.9% | 170,631 | +20.8% | 0.02% | +25.0% |
| Q1 2023 | $3,245,661 | +17.1% | 141,300 | +43.2% | 0.01% | +20.0% |
| Q4 2022 | $2,771,496 | +56.1% | 98,700 | +57.2% | 0.01% | +25.0% |
| Q3 2022 | $1,776,000 | +5.1% | 62,800 | -17.6% | 0.01% | +14.3% |
| Q2 2022 | $1,690,000 | +260.3% | 76,227 | +649.6% | 0.01% | +250.0% |
| Q3 2021 | $469,000 | -79.3% | 10,169 | -75.3% | 0.00% | -75.0% |
| Q2 2021 | $2,265,000 | -77.1% | 41,115 | -78.6% | 0.01% | -81.8% |
| Q1 2021 | $9,898,000 | -34.9% | 191,679 | -45.4% | 0.04% | -34.3% |
| Q4 2020 | $15,207,000 | +20.7% | 350,951 | -2.5% | 0.07% | +34.0% |
| Q3 2020 | $12,597,000 | +99.1% | 359,925 | +204.2% | 0.05% | +56.2% |
| Q2 2020 | $6,328,000 | +2957.0% | 118,335 | +1926.3% | 0.03% | +3100.0% |
| Q1 2020 | $207,000 | -38.6% | 5,840 | -17.3% | 0.00% | 0.0% |
| Q4 2019 | $337,000 | -64.1% | 7,065 | -75.7% | 0.00% | -66.7% |
| Q3 2019 | $940,000 | -13.7% | 29,019 | +32.9% | 0.00% | -25.0% |
| Q2 2019 | $1,089,000 | -37.2% | 21,835 | -15.0% | 0.00% | -42.9% |
| Q1 2019 | $1,733,000 | +9.4% | 25,693 | -25.2% | 0.01% | 0.0% |
| Q4 2018 | $1,584,000 | +16.0% | 34,357 | +93.9% | 0.01% | +40.0% |
| Q3 2018 | $1,366,000 | +49.6% | 17,717 | +63.4% | 0.01% | +25.0% |
| Q2 2018 | $913,000 | -25.6% | 10,840 | -27.7% | 0.00% | -33.3% |
| Q1 2018 | $1,227,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |